Tradestie Institutional Equity Comparison Engine

CONX vs ABVX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABVX Overall Edge

ABVX Captures Institutional Edge (3โ€“0 Pillars ยท 8โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abivax SA American Depositary Shares (ABVX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CONX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ABVX at N/M Forward P/E and -6270.4% operating margin (-6.8% YoY). In options structure, CONX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABVX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CONX N/M vs ABVX N/M Fwd P/E
Growth & Margin Winner ABVX
Op Margin N/A vs -6270.4% ยท YoY N/A vs -6.8%
Momentum & Technical Winner ABVX
1Y -89.0% vs -17.1% ยท 52W Pos 0% vs 18%
Options & Structure Winner ABVX
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (<1st %ile IV)
CONX US Equity
CONX
Institutional Equity
$2.66
-11.75% 1D
Market Cap N/A
1M Return -54.66%
1Y Return -88.97%
Forward P/E N/M
Unified AI Score
42.0 / 100 HOLD
Tech 25.0 Fund 54.0 Flow 50.0 Mom 55.0
ABVX NASDAQ
Abivax SA American Depositary Shares
Pharmaceutical Preparations
$83.61
-4.53% 1D
Market Cap $7.7B
1M Return -5.13%
1Y Return -17.14%
Forward P/E N/M
Unified AI Score
55.3 / 100 HOLD
Tech 42.0 Fund 48.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CONX -88.97% ABVX -17.14% Spread: +62.99 pp (ABVX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CONX TTM Op. Margin: N/A ABVX TTM Op. Margin: -6270.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CONX vs ABVX. Trailing 12-month operating profitability (CONX N/A vs ABVX -6270.4%) and valuation multiples (CONX N/M vs ABVX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CONX (0) vs ABVX (8)
Institutional Metric CONX ABVX Criterion Row Winner
Market Capitalization Scale N/A $7.7B Larger Scale ABVX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A -6.8% Higher Growth ABVX
Operating Margin (TTM) Profitability N/A -6270.4% Higher Margin ABVX
Net Profit Margin Profitability N/A 0.0% Higher Margin ABVX
Return on Equity (ROE) Capital Efficiency N/A -252.3% Higher ROE ABVX
52-Week Range Position Momentum 0% ($3โ€“$28) 18% ($70โ€“$149) Stronger Trend ABVX
Beta / 30D Volatility Risk Regime 4.88ฮฒ ยท 135% Vol 1.40ฮฒ ยท 49% Vol Lower Realized Risk ABVX
Unified Institutional Score Composite Signal 42.0 / 100 (HOLD) 55.3 / 100 (HOLD) Higher Composite ABVX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CONX vs ABVX Buy Guide
CONX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CONX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABVX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live ABVX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CONX nor ABVX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.